Attached files

file filename
EX-32.1 - EXHIBIT 32.1 SECTION 906 CERTIFICATION - PROTHENA CORP PUBLIC LTD COprta201610-kxex321.htm
10-K - FORM 10-K - PROTHENA CORP PUBLIC LTD COprta201610-k.htm
EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - PROTHENA CORP PUBLIC LTD COprta201610-kxex312.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - PROTHENA CORP PUBLIC LTD COprta201610-kxex311.htm
EX-21.1 - EXHIBIT 21.1 LIST OF SUBSIDIARIES - PROTHENA CORP PUBLIC LTD COprta201610-kex211listofsub.htm
EX-10.28 - EXHIBIT 10.28 OFFER LETTER - CAROL KARP - PROTHENA CORP PUBLIC LTD COprta201610-kex1028xcarolka.htm
EX-10.27 - EXHIBIT 10.27 DAVID MCNINCH SEPARATION AGREEMENT - PROTHENA CORP PUBLIC LTD COprta201610-kex1027xdavidmc.htm
EX-10.6 - EXHIBIT 10.6 COMMERCIAL SUPPLY AGREEMENT WITH RENTSCHLER - PROTHENA CORP PUBLIC LTD COprta201610-kex106commercia.htm


Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
The Board of Directors
Prothena Corporation plc:
We consent to the incorporation by reference in the registration statements (Nos. 333-196572, 333-187726 and 333-211653) on Form S-8 and the registration statements (Nos. 333-196965, 333-193416, 333-197006 and 333‑203258) on Form S-3 of Prothena Corporation plc of our reports dated February 24, 2017 with respect to the consolidated balance sheets of Prothena Corporation plc as of December 31, 2016 and 2015, and the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2016, and the effectiveness of internal control over financial reporting as of December 31, 2016, which reports appear in the December 31, 2016 annual report on Form 10‑K of Prothena Corporation plc.


/s/ KPMG LLP
San Francisco, California
February 24, 2017